이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Becton Dickinson 미래 성장
Future 기준 확인 2/6
Becton Dickinson (는) 각각 연간 18% 및 5.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 17.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 15.5% 로 예상됩니다.
주요 정보
18.0%
수익 성장률
17.5%
EPS 성장률
| Medical Equipment 수익 성장 | 16.7% |
| 매출 성장률 | 5.4% |
| 향후 자기자본 수익률 | 15.5% |
| 애널리스트 커버리지 | Good |
| 마지막 업데이트 | 14 Jun 2024 |
최근 미래 성장 업데이트
Recent updates
Is Becton Dickinson (NYSE:BDX) Using Too Much Debt?
May 24
Becton, Dickinson and Company: Stagnating All Along
May 16Investors Still Waiting For A Pull Back In Becton, Dickinson and Company (NYSE:BDX)
Mar 23Estimating The Fair Value Of Becton, Dickinson and Company (NYSE:BDX)
Feb 29Becton Dickinson's (NYSE:BDX) Conservative Accounting Might Explain Soft Earnings
Feb 08Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 03These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Feb 01Becton, Dickinson: 4 Reasons To Buy This Growth At A Reasonable Price Play
Jan 22Becton Dickinson's (NYSE:BDX) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 30Becton, Dickinson And Company: Strong Q4 But Clouded By 75bps Growth Headwind From China In FY24
Nov 13Becton Dickinson's (NYSE:BDX) Upcoming Dividend Will Be Larger Than Last Year's
Nov 12Becton, Dickinson and Company's (NYSE:BDX) Intrinsic Value Is Potentially 26% Above Its Share Price
Nov 06With EPS Growth And More, Becton Dickinson (NYSE:BDX) Makes An Interesting Case
Oct 05Becton, Dickinson Stock Is A Hold, Here's Why
Oct 04Becton, Dickinson: Ahead Of Schedule, Undervalued, And With Some Positive Drivers
Aug 30We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Aug 13Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Jul 28Here's Why We Think Becton Dickinson (NYSE:BDX) Is Well Worth Watching
Jun 22Becton, Dickinson and Company: Still Not Very Healthy
Jun 20Becton, Dickinson: Business Should Beat H2 2023 Expectations
Jun 08These 4 Measures Indicate That Becton Dickinson (NYSE:BDX) Is Using Debt Reasonably Well
Apr 22Is Now The Time To Put Becton Dickinson (NYSE:BDX) On Your Watchlist?
Mar 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Mar 05Becton, Dickinson HPV test Onclarity gets FDA nod for expanded use
Feb 21Becton, Dickinson wins FDA nod for flu, COVID, RSV combo test
Feb 08Becton, Dickinson Q1 2023 Earnings Preview
Feb 01Becton, Dickinson declares $0.91 dividend
Jan 24We Think Becton Dickinson (NYSE:BDX) Can Stay On Top Of Its Debt
Jan 09CerTest/Becton, Dickinson's test for monkeypox gets FDA emergency use nod
Jan 09Becton, Dickinson: A Quality Defensive Pick For 2023
Dec 20Estimating The Intrinsic Value Of Becton, Dickinson and Company (NYSE:BDX)
Dec 01Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $0.91
Nov 13Becton, Dickinson Q4 2022 Earnings Preview
Nov 09Becton, Dickinson, Biocorp team up for traceability of injectable drugs
Oct 18수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 9/30/2026 | 22,642 | 2,808 | 4,108 | 5,079 | 11 |
| 9/30/2025 | 21,419 | 2,479 | 4,150 | 4,694 | 15 |
| 9/30/2024 | 20,249 | 2,094 | 2,973 | 3,834 | 16 |
| 3/31/2024 | 19,716 | 1,364 | 3,025 | 3,760 | N/A |
| 12/31/2023 | 19,492 | 1,265 | 2,649 | 3,431 | N/A |
| 9/30/2023 | 19,372 | 1,470 | 2,115 | 2,989 | N/A |
| 6/30/2023 | 19,046 | 1,582 | 1,878 | 2,773 | N/A |
| 3/31/2023 | 18,809 | 1,556 | 1,009 | 1,966 | N/A |
| 12/31/2022 | 18,738 | 1,486 | 1,361 | 2,359 | N/A |
| 9/30/2022 | 18,870 | 1,545 | 1,661 | 2,634 | N/A |
| 6/30/2022 | 18,958 | 1,412 | 1,465 | 2,575 | N/A |
| 3/31/2022 | 18,924 | 1,430 | 2,041 | 3,141 | N/A |
| 12/31/2021 | 18,534 | 1,079 | 2,620 | 3,751 | N/A |
| 9/30/2021 | 19,131 | 1,514 | 3,453 | 4,647 | N/A |
| 6/30/2021 | 19,066 | 1,486 | 4,222 | 5,177 | N/A |
| 3/31/2021 | 18,313 | 1,379 | 4,150 | 5,064 | N/A |
| 12/31/2020 | 18,207 | 1,507 | 3,476 | 4,359 | N/A |
| 9/30/2020 | 16,074 | 245 | 2,728 | 3,497 | N/A |
| 6/30/2020 | 16,917 | 786 | 2,474 | 3,429 | N/A |
| 3/31/2020 | 17,414 | 923 | 2,509 | 3,499 | N/A |
| 12/31/2019 | 17,355 | 760 | 2,835 | 3,798 | N/A |
| 9/30/2019 | 17,290 | 1,081 | 2,373 | 3,330 | N/A |
| 6/30/2019 | 17,108 | 784 | 2,359 | 3,265 | N/A |
| 3/31/2019 | 17,036 | 926 | 2,009 | 2,875 | N/A |
| 12/31/2018 | 17,063 | 894 | 1,906 | 2,790 | N/A |
| 9/30/2018 | 15,983 | 159 | 1,970 | 2,865 | N/A |
| 6/30/2018 | 14,747 | 621 | 1,837 | 2,685 | N/A |
| 3/31/2018 | 13,503 | -99 | 1,681 | 2,527 | N/A |
| 12/31/2017 | 12,251 | 294 | N/A | 2,555 | N/A |
| 9/30/2017 | 12,093 | 1,030 | N/A | 2,550 | N/A |
| 6/30/2017 | 12,158 | 759 | N/A | 2,129 | N/A |
| 3/31/2017 | 12,321 | 1,314 | N/A | 2,579 | N/A |
| 12/31/2016 | 12,419 | 1,309 | N/A | 2,411 | N/A |
| 9/30/2016 | 12,483 | 976 | N/A | 2,559 | N/A |
| 6/30/2016 | 12,312 | 1,139 | N/A | 2,532 | N/A |
| 3/31/2016 | 12,234 | 810 | N/A | 2,236 | N/A |
| 12/31/2015 | 11,217 | 688 | N/A | 1,907 | N/A |
| 9/30/2015 | 10,282 | 695 | N/A | 1,730 | N/A |
| 6/30/2015 | 9,410 | 815 | N/A | 1,591 | N/A |
| 3/31/2015 | 8,448 | 1,079 | N/A | 1,492 | N/A |
| 12/31/2014 | 8,468 | 1,150 | N/A | 1,677 | N/A |
| 9/30/2014 | 8,446 | 1,185 | N/A | 1,746 | N/A |
| 6/30/2014 | 8,345 | 974 | N/A | 1,876 | N/A |
| 3/31/2014 | 8,239 | 941 | N/A | 1,830 | N/A |
| 12/31/2013 | 8,169 | 930 | N/A | 1,626 | N/A |
| 9/30/2013 | 8,054 | 929 | N/A | 1,505 | N/A |
| 6/30/2013 | 7,920 | 1,114 | N/A | 1,405 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: BDX 의 연간 예상 수익 증가율( 18% )이 saving rate( 2.4% 보다 높습니다. ).
수익 vs 시장: BDX 의 연간 수익( 18% ) US 시장( 14.9% 보다 빠르게 성장할 것으로 예상됩니다. 14.9% 연간).
고성장 수익: BDX 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: BDX 의 수익(연간 5.4% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).
고성장 수익: BDX 의 수익(연간 5.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: BDX 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 15.5 %).